MedTrace Logo

Impact of Vaccination in Acute COVID-19

NCT05198453 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 529

Last updated 2022-02-03

No results posted yet for this study

Summary

The aim of this study was to evaluate the association between vaccination with one of the four SARS-CoV-2 vaccines authorized for use in the European Union-BNT162b2, ChAdOx-1S, mRNA-1273 or Ad.26.COV2.S-and progression to critically severe disease among adult patients with PCR-confirmed acute COVID-19.

Conditions

Interventions

BIOLOGICAL

vaccination

patients who received COVID-19 vaccine

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-16
Primary Completion
2021-12-23
Completion
2022-01-10
FDA Drug
Yes

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05198453 on ClinicalTrials.gov